obefazimod — NDA/BLA submission
Late 2026
• End of 2026 – Planned NDA submission for obefazimod in UCSource filing
ABVX biotech catalysts & pipeline
ABIVAX SA · Data as of 2026-10-25
Upcoming catalysts
obefazimod — Topline data
Mid-2027
• Mid-2027 – Topline results from the Phase 2b ENHANCE-CD induction trial evaluating obefazimod in CDSource filing